Latest Breaking News On - Pharma intelligence center - Page 1 : vimarsana.com

Climate Change Fuels Surge in Multiple Sclerosis Cases

Climate change-induced exacerbations will increase the number of multiple sclerosis cases.

Sanofi aubagioJos opdenakkerPharma analystCompare newExisting standards globaldataPharma intelligence center

Radiomics research identifies new imaging markers in laryngeal cancer

Amar Rajgor and his team at Newcastle University are now planning a 250-patient study to improve laryngeal cancer outcomes.

Newcastle upon tyneUnited kingdomAmar rajgorDevice networkNational institute for healthCare researchGlobaldata pharma intelligence centerNewcastle universityNewcastle upon tyne hospitalsPharma intelligence centerUrban chinaNational instituteMedical device network

Dementia Action Week 2024: the future of Alzheimer s diagnostics

Dementia Action Week 2024: the future of Alzheimer s diagnostics
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Eli lilyEisai leqembiJohn mcdonoughDrug administrationDevice networkGlobaldata pharma intelligence centerDementia action weekMassachusetts based sunbird bioPharma intelligence centerAction weekMedical device network

Analog Devices s Sensinel CPM system reduces heart fluid in published study

Analog Devices s Sensinel CPM system reduces heart fluid in published study
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Glasgow cityUnited kingdomPardeep jhundGlobaldata pharma intelligence centerEuropean society of cardiology heart failure congressDrug administrationClyde researchUniversity of glasgowScottish national advanced heart failure unitQueen elizabeth university hospitalAnalog devicesEuropean journalHeart failureEuropean societyHeart failure congressPharma intelligence center

Pioneer Institute study finds IRA discourages non-opioid drug innovation

The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.

United statesRobert popovianPioneer instituteBiotechnology industry organizationDrug administrationGlobaldata pharma intelligence centerVertex pharmaceuticalsReduction actPharma intelligence centerIndustry organizationPharmaceutical technologyPain medicationsPioneer instituteOpioid crisisOpioid addictionPrescription drugs